Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AVDL | US
0.25
1.72%
Healthcare
Biotechnology
31/03/2024
05/07/2024
14.78
14.54
14.82
14.33
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin Ireland.
View LessSmallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.5%1 month
35.7%3 months
42.9%6 months
51.4%-
-
16.52
0.47
0.22
-9.03
48.13
0.07
-133.87M
1.42B
1.42B
-
-95.79
-
-100.00
-779.92
9.17
8.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.94
Range1M
2.63
Range3M
5.67
Rel. volume
0.63
Price X volume
17.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kura Oncology Inc | KURA | Biotechnology | 20.01 | 1.52B | -0.25% | n/a | 3.36% |
KEROS THERAPEUTICS INC. | KROS | Biotechnology | 42.21 | 1.52B | 0.09% | n/a | 3.13% |
Ligand Pharmaceuticals Incorporated | LGND | Biotechnology | 84.37 | 1.52B | 2.02% | 15.75 | 0.77% |
Akero Therapeutics Inc | AKRO | Biotechnology | 21.45 | 1.48B | -2.19% | n/a | 4.28% |
Dynavax Technologies Corporation | DVAX | Biotechnology | 11.25 | 1.47B | 2.09% | 160.43 | 41.41% |
Array BioPharma Inc | ARRY | Biotechnology | 9.62 | 1.46B | -4.85% | 27.00 | 114.13% |
MannKind Corporation | MNKD | Biotechnology | 5.13 | 1.40B | 1.99% | 130.50 | -162.73% |
Bicycle Therapeutics Limited | BCYC | Biotechnology | 20.21 | 1.39B | 3.22% | n/a | 12.31% |
Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 19.36 | 1.37B | 1.36% | 143.62 | 2.81% |
Longboard Pharmaceuticals Inc. Common Stock | LBPH | Biotechnology | 34.87 | 1.36B | 9.28% | n/a | 1.27% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Steelcase Inc | SCS | Building Products & Equipment | 12.82 | 1.46B | -0.93% | 17.05 | 69.98% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.45 | 1.31B | -0.37% | n/a | 20.15% |
REV Group Inc | REVG | Recreational Vehicles | 24.74 | 1.28B | -2.06% | 5.86 | 66.74% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.36 | 1.14B | 1.60% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -9.03 | -2.43 | Cheaper |
Ent. to Revenue | 48.13 | 4,101.76 | Cheaper |
PE Ratio | - | 41.26 | - |
Price to Book | 16.52 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 42.86 | 76.52 | Lower Risk |
Debt to Equity | 0.47 | 0.51 | Par |
Debt to Assets | 0.22 | 0.24 | Par |
Market Cap | 1.42B | 3.77B | Emerging |